Insilico Medicine advances generative AI-designed COVID-19 drug (IMAGE)

InSilico Medicine

Insilico Medicine advances generative AI-designed COVID-19 drug

Caption

Insilico Medicine will send its generative AI-designed drug for COVID-19 and variants to clinical trials.

Credit

Insilico Medicine

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.